申请人:Curis, Inc.
公开号:US20140221343A1
公开(公告)日:2014-08-07
The present invention relates to HSP90 inhibitors containing fused amino pyridine core that are useful as inhibitors of HSP90 and their use in the treatment of HSP90 related diseases and disorders such as cancer, an autoimmune disease, or a neurodegenerative disease.
本发明涉及含有融合氨基吡啶核的HSP90抑制剂,其可作为HSP90的抑制剂,并用于治疗HSP90相关疾病和疾病,如癌症、自身免疫性疾病或神经退行性疾病。